Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.
Level V
Where this comes from
- Record sourced from PubMed, PMID 30667474.
- Also identified by DOI 10.1001/jamainternmed.2018.8121 and PMC identifier 6503563.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This nationwide survey of US primary care internists and medical specialists evaluates physicians’ attitudes about the US Food and Drug Administration’s drug approval standards and off-label drug marketing.
Medical subject headings
- Attitude of Health Personnel
- Drug Approval
- Off-Label Use
- Practice Patterns, Physicians'